CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test
Are you or your loved one experiencing progressive neurological symptoms? DNA Labs UAE offers the CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test, a comprehensive genetic test for individuals suspected to have this rare genetic disorder.
Test Details
CSF1R gene leukoencephalopathy, diffuse hereditary, with spheroids is a rare genetic disorder that affects the white matter of the brain. It is characterized by the presence of abnormal protein deposits called spheroids, which can cause progressive neurological symptoms.
NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology. This type of genetic test can analyze multiple genes simultaneously, including the CSF1R gene, to identify any mutations or variations that may be associated with leukoencephalopathy with spheroids.
By performing NGS genetic testing, healthcare professionals can determine if a person carries any genetic variants in the CSF1R gene that may be responsible for the development of this condition. This information can be used for diagnosis, genetic counseling, and potentially guiding treatment decisions.
It is important to note that genetic testing for CSF1R gene leukoencephalopathy is typically ordered by a healthcare professional who specializes in genetics or neurology. They will assess the individual’s symptoms, medical history, and family history before determining if genetic testing is appropriate.
Test Components and Price
- Test Name: CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
Sample Condition and Report Delivery
The sample required for this genetic test can be either blood, extracted DNA, or one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks.
Test Type and Doctor
This genetic test falls under the category of Neurological Disorders. It is recommended to consult a Neurologist for further guidance and interpretation of the test results.
Test Department and Pre Test Information
This genetic test is conducted by the Genetics department. Before undergoing the CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with CSF1R Gene Leukoencephalopathy, diffuse hereditary, with spheroids.
Conclusion
With the CSF1R Gene Leukoencephalopathy Diffuse Hereditary with Spheroids Genetic Test offered by DNA Labs UAE, individuals suspected to have this rare genetic disorder can receive accurate diagnosis, genetic counseling, and potentially guide treatment decisions. By analyzing the CSF1R gene using NGS technology, healthcare professionals can identify any mutations or variations associated with leukoencephalopathy with spheroids. Consult a healthcare professional specializing in genetics or neurology to determine if this test is appropriate for you or your loved one.
| Test Name | CSF1R Gene Leukoencephalopathy diffuse hereditary with spheroids Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CSF1R Gene Leukoencephalopathy, diffuse hereditary, with spheroids NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CSF1R Gene Leukoencephalopathy, diffuse hereditary, with spheroids |
| Test Details |
CSF1R gene leukoencephalopathy, diffuse hereditary, with spheroids is a rare genetic disorder that affects the white matter of the brain. It is characterized by the presence of abnormal protein deposits called spheroids, which can cause progressive neurological symptoms. NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology. This type of genetic test can analyze multiple genes simultaneously, including the CSF1R gene, to identify any mutations or variations that may be associated with leukoencephalopathy with spheroids. By performing NGS genetic testing, healthcare professionals can determine if a person carries any genetic variants in the CSF1R gene that may be responsible for the development of this condition. This information can be used for diagnosis, genetic counseling, and potentially guiding treatment decisions. It is important to note that genetic testing for CSF1R gene leukoencephalopathy is typically ordered by a healthcare professional who specializes in genetics or neurology. They will assess the individual’s symptoms, medical history, and family history before determining if genetic testing is appropriate. |
